BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1321 related articles for article (PubMed ID: 8832942)

  • 1. Action profiles of predictors of death and survival time in stage I malignant melanoma.
    Helfenstein U; Schuler G; Morf S; Schuler D
    Dermatology; 1996; 192(1):1-7. PubMed ID: 8832942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of generalised additive models (GAM) in dentistry.
    Helfenstein U; Steiner M; Menghini G
    Community Dent Health; 1997 Dec; 14(4):221-6. PubMed ID: 9458579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG; Leiter U; Eigentler TK; Garbe C
    Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
    Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
    J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Garbe C; Orfanos CE
    Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
    Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
    Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age as a prognostic factor in the malignant melanoma population.
    Austin PF; Cruse CW; Lyman G; Schroer K; Glass F; Reintgen DS
    Ann Surg Oncol; 1994 Nov; 1(6):487-94. PubMed ID: 7850555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of interactions between prognostic factors of stage I malignant melanoma.
    Helfenstein U; Schüler G; Bopp M; Morf S; Schüler D
    Melanoma Res; 1996 Aug; 6(4):319-24. PubMed ID: 8873052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of Danish cancer patients 1943-1987. Malignant melanoma of the skin.
    Osterlind A; Kjems E
    APMIS Suppl; 1993; 33():149-55. PubMed ID: 8512737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics.
    Luen S; Wong SW; Mar V; Kelly JW; McLean C; McArthur GA; Haydon A
    Am J Clin Oncol; 2018 Jan; 41(1):90-94. PubMed ID: 26325493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
    Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
    J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland.
    Minini R; Rohrmann S; Braun R; Korol D; Dehler S
    Melanoma Res; 2017 Apr; 27(2):145-151. PubMed ID: 27926588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test.
    Hsueh EC; DeBloom JR; Lee J; Sussman JJ; Covington KR; Middlebrook B; Johnson C; Cook RW; Slingluff CL; McMasters KM
    J Hematol Oncol; 2017 Aug; 10(1):152. PubMed ID: 28851416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
    J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
    Green AC; Baade P; Coory M; Aitken JF; Smithers M
    J Clin Oncol; 2012 May; 30(13):1462-7. PubMed ID: 22412152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and incidence of primary mucosal melanoma: a population-based study in France.
    Beaudoux O; Riffaud L; Barbe C; Grange F
    Eur J Dermatol; 2018 Oct; 28(5):654-660. PubMed ID: 30378540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
    Eigentler TK; Buettner PG; Leiter U; Garbe C;
    J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype.
    Brunssen A; Jansen L; Eisemann N; Waldmann A; Weberpals J; Kraywinkel K; Eberle A; Holleczek B; Zeissig SR; Brenner H; Katalinic A;
    J Am Acad Dermatol; 2019 Apr; 80(4):938-946. PubMed ID: 30244061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification.
    Büttner P; Garbe C; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
    Cancer; 1995 May; 75(10):2499-2506. PubMed ID: 7736394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.